Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake?

Figure 1

Chemical structures of the clinically approved and marketed Pt(II) anticancer drugs.

(a)

(b)

(c)

(d)

(e)

(f)

(g)